22
DAFTAR PUSTAKA
Adam, J. M. F., 2000, Klasifikasi dan Kriteria Diagnosis Diabetes Melitus yang Baru, Cermin Dunia Kedokteran, ISSN; 0125-913X No. 127, 37-40
Alder, M., 1998, Evidence for Direct Action of Alloxan to Induce Insulin Resistance at the Cellular level. Diabetologia, 41, 1327-1336.
Anonim, 2005, http://www.depkes.go.id, Jumlah Penderita Diabetes Indonesia Ranking ke-4 di Dunia, DepKes RI, Jakarta, diakses pada tanggal 17 April 2008
Bochner, F., Caaruthers, G., Kampmann, J., Steiner J and Azarnoff, D.L., 1978, Handbook of Clinical Pharmacology, 1st Ed, 293-294, Brown and Company, Boston.
Buening, G.K., Chanh, R.L., Huang, M.T., Fortner, J.G., Wood, A.W., and Conney, A.H., 1981, Activation and Inhibition of Benzo (a) piren and Aflatoxin B, Metabolisme in Human Liver Microsomes, Drug Metab. Drug Dispos, 22, 4.
Caterson, I.D., Boyages, S.C., Brooks, B., Capstick, F., Donnelly, R., Feely,J., Handelsman, D.J., Lewitt, M., Qu, X., Steinbeck, K.S., Swaraj, S., Turtle, J.R., and Yue, D.K., 1996, Endocrine Disease, In Speight, T.M and Holfors, N.H.G., (Ed), Avery’s Drug Treatment, 4th Ed, 725-749, ADS International, Aucland.
Coskun, O., Kanter, M., Korkmaz, A., and Oter, S., 2005, Rutin, a Flavonoid Antioxidant, Prevent and Protects Streptozotocin Induced Oxidative Stress and Beta Cell Damage in Rat Pancreas, Pharmacol Res, 51 (2) : 117-123
Donatus, 1994, Antaraksi Kurkumin dengan Parasetamol : Kajian terhadap Aspek Farmakologi dan Toksikologi Perubahan Hayati Parasetamol, Disertasi, UGM, Yogyakarta.
Gibson, G.G., and Skett, P., 1991, Pengantar Metabolisme Obat (terjemahan oleh Aisyiah, I.B), Penerbit UI, Jakarta.
23
Harborne, J.B., 1986, The Flavonoids : Advances in Research since 1986, Chapman & Hall/ CRC, A. CRC Press Company, Boca Rotan London New York Washington, D.C.
Harper, H.A., Rodwel, U.W., and Mayes, P.A., 1977, Review of Physiological Chemistry, 10th Ed, 470-481, Large Medical Publication Maruzen Company Limited, Los Altos.
Hu, Oliver, Y., Wang, H., Hsiong, Cheng-huei, Pao, Li-heng, 2006, Cytochrome P450 2C9 inhibitors, United States Patent 200600069042, www.freepatentsonline.com, diakses tanggal 28 Agustus 2008.
Hussar, D.A., 1995, Drug Interaction, Remington : The Science and Practise of Pharmacy, vol 11, 19th Ed, 1822-1836, Mack Publishing Companya Easton, Pennsylvania.
Katsumata, K., Katsumata, K., Jr., and Katsumata, Y., 1992, Protective Effect of Diltiazem Hydrochloride on the Occurrence of Alloxan or Streptozotocin Induced Diabetes in Rats, Horm. Metab. Res, 24 : 508-510.
Knect, P., et al., 1997, Dietary Flavonoids and the Risk of Lung Cancer and Other Malignant Neoplasma, Am. J. Epidemiol, 146 : 223
Laychock, S.G., 1995, Carbohidrat Metabolism, Insulin and Oral Hypoglycemic Agents, ins Smith, C.M. and Renard W.B., Essential of Pharmacology, 588-594, WB., Saunder Company, London.
Markham, K.R., 1988, Cara Mengidentifikasi Flavonoid, Penerbit ITB, Bandung.
Miners, J.O., and Birkett, D.J., 1998, Cytochrome P450 2C9 : an Enzyme of Major Importance in Human Drug Metabolism, Br J Clin Pharmacol, 45 (6) : 525-538.
Mycek, M. J., Harvey, R. A., Champe, P. C. C., and Fisher, B. D., 2001, Farmakologi Ulasan Bergambar, diterjemahkan oleh Agoes, A., Edisi 2, 259-261, Widya Medika, Jakarta.
Mutschler, E., 1986, Dinamika Obat, Edisi V, diterjemahkan oleh Widianto, M., dan Ranti, A.S., ITB, Bandung.
24
Park, B.H., 1995, Protective Mechanism of Glucose against Alloxan Induced Pancreatic β-cell Damage, Biochem. Biophys. Res. Commun, 210, 1-6.
Rees, D.A and Alcolado, J.C. 2005, Animal Models of Diabetes Mellitus, Diabetic Medicine, 22 : 259-370
Rosen, P., Tritschler, H.J., and Packer, L., 2002, Vascular Complications in Diabetes : Mechanisms and the Influence of Antioxidans, 511-524, in Handbook of Antioxidants, second edition Revised and Expanded, edited by Enrique Cadenas and Lester Packer, New York.
Scott, J.A., and King, G.L., 2004, Oxidative Stress and Antioxidant Treatment in Diabetes, Ann.N.Y. Acad. Sci. 1031 : 204-213, New York
Sergio, I.A., Cristin, R.M., Jorge E, Ana, C.P., Miguel, A.P., and Alfredo, F.V., 2000, Streptozotocin and Alloxan in Experimental Diabetes : Comparison of the Two Models in Rats, Acta Histochem. Cytochem, 33 (3), 201-208.
Setiawati, A, 1995, Interaksi Obat, dalam Ganiswara, S.G. (Ed), Farmakologi dan Terapi, Ed IV, 800-810, Bagian Farmakologi, FK UI, Jakarta.
Shargel, L., and Yu, A.B.C., 2005, Biofarmasetika dan Farmakokinetika terapan, Edisi kedua, Airlangga University Press.
Shibasaki, J., Konishi, R., Morishita, T., and Ueki, T., 1973, Drug Abs, Metab and Excretion some New Aspets of Pharmacokinetic on Tolbutamide in Rabbits, Chem.Phar.Bull. 21 (8) : 1754-1763.
Soegondo, S., Soewondo, P., dan Subekti, I., 2005, Penatalaksanaan Diabetes Melitus Terpadu, Cetakan ke-5, Balai Penerbit FKUI, Jakarta.
Sudjarwo, S.A., 2005, Analgesic and Antiinflammatory Activities fo Rutin, Acta Pharmaceutica Indonesia, Vol 30, No 3, Hal 80-82, ISSN : 0216-616X
Szkudelski, T., 2001, The Mechanism of Alloxan and Streptozotocin Action in β Cells of Rat Pancreas, Minireview, Physiol. Res. 50 : 536-546.
Walde, S.S., Dohle, C., Schott-Ohly, P., and Glechmann, H., 2002, Molecular Target Structures in Alloxan-Induced Diabetes in Mice, Life Sciences, 71, 1681-1694
25
Widowati, L., Dzulkarnain, B., dan Sa’roni, 1997, Tanaman Obat untuk Diabetes Mellitus, Cermin Dunia Kedokteran, 116, 53-60.
Wilson, G.L., Patton, N.J, McCord JM, Mullins, D.W., and Mossman, B.T., 1984, Mechanism of Streptozotocin and Alloxan Induced Damage in Rat β Cells, Diabetologia, 27 (6):587-591.
